BRIEF RESEARCH REPORT
Accepted on 29 May 2025
An in silico evaluation of lorlatinib as a potential therapy for novel amino acid substitutions in the tyrosine kinase domain of the ALK protein associated with cancer
doi 10.3389/fphar.2025.1605314
- Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Discovery of Small Molecule Lead Compounds: a Driving Force to Unravel New Anti-Cancer Targets and Mechanisms - Volume III
Discovery of Small Molecule Lead Compounds: a Driving Force to Unravel New Anti-Cancer Targets and Mechanisms - Volume III
75
Total downloads
1,078
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Accepted on 27 May 2025
Structure-Based Molecular Screening and dynamic simulation of Phytocompounds Targeting VEGFR-2: A Novel Therapeutic Approach for Papillary Thyroid Carcinoma
doi 10.3389/fphar.2025.1583329
ORIGINAL RESEARCH
Published on 15 May 2025
Wogonin inhibits the proliferation of prolactinoma through the PI3K/AKT signaling pathway
doi 10.3389/fphar.2025.1546285
- 456 views
Published in
Frontiers in Oncology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Pharmacology
- 4.4 impact factor
- 7.8 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: